Go Pro

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Align Technology, Inc. stock logo
ALGN
Align Technology
$180.59
+0.6%
$171.60
$122.00
$208.30
$12.85B1.671.04 million shs486,760 shs
Pfizer Inc. stock logo
PFE
Pfizer
$24.46
+1.2%
$25.32
$23.11
$28.75
$137.76B0.3547.17 million shs42.73 million shs
Health Care Select Sector SPDR Fund stock logo
XLV
Health Care Select Sector SPDR Fund
$161.41
+0.4%
$152.27
$127.96
$165.60
$41.48B0.5612.37 million shs6.87 million shs
7 Stocks That Will Be Magnificent in 2026 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Align Technology, Inc. stock logo
ALGN
Align Technology
+0.64%-4.14%+3.29%-2.22%-10.72%
Pfizer Inc. stock logo
PFE
Pfizer
+1.02%+3.04%-6.60%-9.84%-4.64%
Health Care Select Sector SPDR Fund stock logo
XLV
Health Care Select Sector SPDR Fund
+0.35%-0.34%+4.94%+8.45%+19.39%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Align Technology, Inc. stock logo
ALGN
Align Technology
$180.59
+0.6%
$171.60
$122.00
$208.30
$12.85B1.671.04 million shs486,760 shs
Pfizer Inc. stock logo
PFE
Pfizer
$24.46
+1.2%
$25.32
$23.11
$28.75
$137.76B0.3547.17 million shs42.73 million shs
Health Care Select Sector SPDR Fund stock logo
XLV
Health Care Select Sector SPDR Fund
$161.41
+0.4%
$152.27
$127.96
$165.60
$41.48B0.5612.37 million shs6.87 million shs
7 Stocks That Will Be Magnificent in 2026 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Align Technology, Inc. stock logo
ALGN
Align Technology
+0.64%-4.14%+3.29%-2.22%-10.72%
Pfizer Inc. stock logo
PFE
Pfizer
+1.02%+3.04%-6.60%-9.84%-4.64%
Health Care Select Sector SPDR Fund stock logo
XLV
Health Care Select Sector SPDR Fund
+0.35%-0.34%+4.94%+8.45%+19.39%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Align Technology, Inc. stock logo
ALGN
Align Technology
2.80
Moderate Buy$206.0714.11% Upside
Pfizer Inc. stock logo
PFE
Pfizer
2.19
Hold$28.5016.51% Upside
Health Care Select Sector SPDR Fund stock logo
XLV
Health Care Select Sector SPDR Fund
2.76
Moderate Buy$161.41N/A

Current Analyst Ratings Breakdown

Latest XLV, ALGN, and PFE Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/13/2026
Pfizer Inc. stock logo
PFE
Pfizer
Lower Price TargetOutperform$34.00 ➝ $30.00
7/13/2026
Pfizer Inc. stock logo
PFE
Pfizer
Lower Price TargetBuy$36.00 ➝ $35.00
7/10/2026
Pfizer Inc. stock logo
PFE
Pfizer
Lower Price TargetNeutral$27.00 ➝ $26.00
7/8/2026
Align Technology, Inc. stock logo
ALGN
Align Technology
Initiated CoverageMarket PerformOutperform$209.00
7/8/2026
Align Technology, Inc. stock logo
ALGN
Align Technology
UpgradeStrong-Buy
7/8/2026
Pfizer Inc. stock logo
PFE
Pfizer
Lower Price TargetNeutral$30.00 ➝ $28.00
7/6/2026
Pfizer Inc. stock logo
PFE
Pfizer
DowngradeBuyHold$32.00 ➝ $28.00
7/6/2026
Pfizer Inc. stock logo
PFE
Pfizer
Reiterated RatingNeutral$27.00
6/23/2026
Pfizer Inc. stock logo
PFE
Pfizer
Reiterated RatingOutperform
6/9/2026
Pfizer Inc. stock logo
PFE
Pfizer
UpgradeUnderperformSector Perform$25.00
6/4/2026
Align Technology, Inc. stock logo
ALGN
Align Technology
DowngradeHold (C)Hold (C-)
(Data available from 7/13/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Align Technology, Inc. stock logo
ALGN
Align Technology
$4.03B3.21$11.94 per share15.12$56.43 per share3.20
Pfizer Inc. stock logo
PFE
Pfizer
$62.58B2.23$4.45 per share5.50$15.26 per share1.60
Health Care Select Sector SPDR Fund stock logo
XLV
Health Care Select Sector SPDR Fund
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Align Technology, Inc. stock logo
ALGN
Align Technology
$410.35M$5.9630.3017.311.8410.50%15.82%10.17%7/29/2026 (Estimated)
Pfizer Inc. stock logo
PFE
Pfizer
$7.77B$1.3118.678.55N/A11.83%19.44%8.41%8/4/2026 (Estimated)
Health Care Select Sector SPDR Fund stock logo
XLV
Health Care Select Sector SPDR Fund
N/AN/A21.15N/AN/AN/AN/AN/AN/A

Latest XLV, ALGN, and PFE Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/4/2026Q2 2026
Pfizer Inc. stock logo
PFE
Pfizer
$0.68N/AN/AN/A$14.45 billionN/A
7/29/2026Q2 2026
Align Technology, Inc. stock logo
ALGN
Align Technology
$2.56N/AN/AN/A$1.05 billionN/A
5/5/2026Q1 2026
Pfizer Inc. stock logo
PFE
Pfizer
$0.7220$0.75+$0.0280$0.47$13.84 billion$14.45 billion
4/29/2026Q1 2026
Align Technology, Inc. stock logo
ALGN
Align Technology
$2.26$2.58+$0.32$1.57$1.02 billion$1.04 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Align Technology, Inc. stock logo
ALGN
Align Technology
N/AN/AN/AN/AN/A
Pfizer Inc. stock logo
PFE
Pfizer
$1.727.03%-13.20%131.30%16 Years
Health Care Select Sector SPDR Fund stock logo
XLV
Health Care Select Sector SPDR Fund
$2.531.57%N/AN/AN/A

Latest XLV, ALGN, and PFE Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
6/24/2026
Pfizer Inc. stock logo
PFE
Pfizer
quarterly$0.437.15%7/24/20267/24/20269/1/2026
4/22/2026
Pfizer Inc. stock logo
PFE
Pfizer
quarterly$0.436.71%5/8/20265/8/20266/12/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Align Technology, Inc. stock logo
ALGN
Align Technology
N/A
1.39
1.28
Pfizer Inc. stock logo
PFE
Pfizer
0.67
1.25
0.94
Health Care Select Sector SPDR Fund stock logo
XLV
Health Care Select Sector SPDR Fund
N/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
Align Technology, Inc. stock logo
ALGN
Align Technology
88.43%
Pfizer Inc. stock logo
PFE
Pfizer
68.36%
Health Care Select Sector SPDR Fund stock logo
XLV
Health Care Select Sector SPDR Fund
N/A

Insider Ownership

CompanyInsider Ownership
Align Technology, Inc. stock logo
ALGN
Align Technology
0.75%
Pfizer Inc. stock logo
PFE
Pfizer
0.62%
Health Care Select Sector SPDR Fund stock logo
XLV
Health Care Select Sector SPDR Fund
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
Align Technology, Inc. stock logo
ALGN
Align Technology
20,29071.62 million71.08 millionOptionable
Pfizer Inc. stock logo
PFE
Pfizer
75,0005.70 billion5.66 billionOptionable
Health Care Select Sector SPDR Fund stock logo
XLV
Health Care Select Sector SPDR Fund
N/A256.96 millionN/ANot Optionable

Recent News About These Companies

Health care breadth thrust points to sector rotation

New MarketBeat Followers Over Time

Media Sentiment Over Time

Align Technology stock logo

Align Technology NASDAQ:ALGN

$180.59 +1.14 (+0.64%)
Closing price 07/13/2026 04:00 PM Eastern
Extended Trading
$179.46 -1.13 (-0.62%)
As of 04:42 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Align Technology, Inc. designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth. The segment also provides Invisalign moderate, lite and express packages, and Invisalign go and Invisalign Go Plus; retention products, Invisalign training, and adjusting tools used by dental professionals during the course of treatment; and Invisalign Palatal Expander, a 3D printed orthodontic device; and 3D printing solutions. Its Imaging Systems and CAD/CAM Services segment offers iTero intraoral scanning system, a single hardware platform for restorative or orthodontic procedures; restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons; and orthodontists software for digital records storage, orthodontic diagnosis, and fabrication of printed models and retainers. This segment also provides Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; Align Oral Health Suite, a digital interface designed to enhance dental consultations; and TimeLapse technology, which allows doctors or practitioners to compare a patient's historic 3D scans to the present-day scan, as well as subscription software, disposables, rentals, leases, pay per scan, and CAD/CAM software solutions. The company was incorporated in 1997 and is headquartered in Tempe, Arizona.

Pfizer stock logo

Pfizer NYSE:PFE

$24.46 +0.29 (+1.20%)
Closing price 07/13/2026 03:59 PM Eastern
Extended Trading
$24.49 +0.03 (+0.12%)
As of 05:07 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Health Care Select Sector SPDR Fund stock logo

Health Care Select Sector SPDR Fund NYSEARCA:XLV

$161.41 +0.57 (+0.35%)
Closing price 07/13/2026 04:10 PM Eastern
Extended Trading
$160.86 -0.55 (-0.34%)
As of 05:03 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Health Care Select Sector SPDR Fund (the Fund) seeks to closely match the returns and characteristics of the S&P Health Care Select Sector Index (the Index). The companies included in the Index are selected on the basis of general industry classification from a universe of companies defined by the Standard & Poor's 500 Composite Stock Index (S&P 500). The Health Care Select Sector Index includes companies from the industries, such as pharmaceuticals, healthcare providers and services, healthcare equipment and supplies, biotechnology, life sciences tools and services, and healthcare technology. Under normal market conditions, the Fund generally invests substantially all, but at least 95%, of its total assets in the securities comprising the Index. State Street Global Advisors acts as the Fund's investment manager.